Boehringer plans to again in­crease R&D spend­ing; Val­ne­va, Pfiz­er to ad­vance Ly­me vac­cine can­di­date

Plus, news about OP­KO, Health­Care Roy­al­ty, In­ven­ti­va, Ex­sci­en­tia and GT Ape­iron:

Boehringer In­gel­heim ups its R&D bud­get: Back in April, the com­pa­ny said it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER